MDxHealth SA Approves New Share Option Plan

Ticker: MDXH · Form: 6-K · Filed: Jun 20, 2024 · CIK: 1872529

Mdxhealth SA 6-K Filing Summary
FieldDetail
CompanyMdxhealth SA (MDXH)
Form Type6-K
Filed DateJun 20, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: share-options, shareholder-meeting, corporate-governance

TL;DR

MDxHealth SA shareholders approved a new option plan and 2M new options on June 20, 2024.

AI Summary

MDxHealth SA held an extraordinary general shareholders' meeting on June 20, 2024, where they approved a new 2024 Share Option Plan and the issuance of 2,000,000 share options. The meeting also included approval for the issuance of additional shares.

Why It Matters

The approval of a new share option plan and issuance of options can impact employee incentives and future share dilution.

Risk Assessment

Risk Level: low — This filing is a routine update on shareholder meeting resolutions and does not indicate significant financial distress or major strategic shifts.

Key Numbers

Key Players & Entities

FAQ

What was the primary purpose of the extraordinary general shareholders' meeting on June 20, 2024?

The primary purpose was to approve a new 2024 Share Option Plan and the issuance of 2,000,000 share options thereunder, along with the approval of additional share issuances.

What is the filing number for this 6-K report?

The SEC file number is 001-40996.

Where is MDxHealth SA's principal executive office located?

The principal executive office is located at CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium.

Did MDxHealth SA file a Form 20-F or 40-F for annual reports?

MDxHealth SA indicated that it files annual reports under cover of Form 20-F.

What is the SIC code for MDxHealth SA?

The Standard Industrial Classification code is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.

Filing Stats: 496 words · 2 min read · ~2 pages · Grade level 16.2 · Accepted 2024-06-20 16:02:47

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: June 20, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing